Global Secondary Progressive Multiple Sclerosis Drug Market Research Report 2015-2025
- HEY3817853
- 104 Pages
- April 2020
- Healthcare
The global Secondary Progressive Multiple Sclerosis Drug market will reach xxx Million USD in 2020 with CAGR xx% 2020-2025. The objective of report is to define, segment, and project the market on the basis of product type, application, and region, and to describe the content about the factors influencing market dynamics, policy, economic, technology and market entry etc.
Based on products type, the report describes major products type share of regional market. Products mentioned as follows:
Inebilizumab
GLX-1112
DC-TAB
Etomoxir
IB-MS
Others
Leading vendors in the market are included based on profile, business performance etc. Vendors mentioned as follows:
AB Science SA
Actelion Ltd
Biogen, Inc.
F. Hoffmann-La Roche Ltd.
Genzyme Corporation
Glialogix, Inc.
Immune Response BioPharma, Inc.
Innate Immunotherapeutics Ltd
Kyorin Pharmaceutical Co., Ltd.
Mallinckrodt Plc
MedDay SA
MedImmune, LLC
Merck KGaA
Meta-IQ ApS
Novartis AG
Opexa Therapeutics, Inc.
Xenetic Biosciences (UK) Limited
Based on Application, the report describes major application share of regional market. Application mentioned as follows:
Hospital
Clinic
Others
Based on region, the report describes major regions market by products and application. Regions mentioned as follows:
Asia-Pacific
North America
Europe
South America
Middle East & Africa
1 Market Overview
1.1 Objectives of Research
1.1.1 Definition
Figure Secondary Progressive Multiple Sclerosis Drug Picture
1.1.2 Specifications
Table Product Specifications of Secondary Progressive Multiple Sclerosis Drug
1.2 Market Segment
1.2.1 by Type
Table Products Segment of Secondary Progressive Multiple Sclerosis Drug
Table Global Secondary Progressive Multiple Sclerosis Drug Market by Type, 2011-2022 (USD Million)
1.2.1.1 Inebilizumab
Table Inebilizumab Overview
1.2.1.2 GLX-1112
Table GLX-1112 Overview
1.2.1.3 DC-TAB
Table DC-TAB Overview
1.2.1.4 Etomoxir
Table Etomoxir Overview
1.2.1.5 IB-MS
Table IB-MS Overview
1.2.1.6 Others
Table Others Overview
1.2.2 by Application
Table Application Segment of Secondary Progressive Multiple Sclerosis Drug
Table Global Secondary Progressive Multiple Sclerosis Drug Market by Application, 2011-2022 (USD Million)
1.2.2.1 Hospital
Table Hospital Overview
1.2.2.2 Clinic
Table Clinic Overview
1.2.2.3 Others
Table Others Overview
1.2.3 by Regions
Table Global Secondary Progressive Multiple Sclerosis Drug Market by Region, 2011-2022 (USD Million)
2 Industry Chain
2.1 Industry Chain Structure
Figure Industry Chain Structure of Secondary Progressive Multiple Sclerosis Drug
2.2 Upstream
Table Cost of Secondary Progressive Multiple Sclerosis Drug
Figure Manufacturing Process of Secondary Progressive Multiple Sclerosis Drug
2.3 Market
2.3.1 SWOT
Figure SWOT of Secondary Progressive Multiple Sclerosis Drug
2.3.2 Dynamics
Table Market Dynamics
3 Environmental Analysis
3.1 Policy
Table Policy of Secondary Progressive Multiple Sclerosis Drug
3.2 Economic
Table GDP of Major Countries
3.3 Technology
Table Technology of Secondary Progressive Multiple Sclerosis Drug
3.4 Market Entry
Table Market Entry of Secondary Progressive Multiple Sclerosis Drug
4 Market Segmentation by Type
4.1 Market Size
4.1.1 Inebilizumab Market, 2013-2018
Figure Inebilizumab Market Size and Growth, 2015-2019 (USD Million)
Figure Inebilizumab Market Size and Growth, 2015-2019 (in Volume)
Table Inebilizumab CAGR by Revenue and Volume, 2015-2019
4.1.2 GLX-1112 Market, 2013-2018
Figure GLX-1112 Market Size and Growth, 2015-2019 (USD Million)
Figure GLX-1112 Market Size and Growth, 2015-2019 (in Volume)
Table GLX-1112 CAGR by Revenue and Volume, 2015-2019
4.1.3 DC-TAB Market, 2013-2018
Figure DC-TAB Market Size and Growth, 2015-2019 (USD Million)
Figure DC-TAB Market Size and Growth, 2015-2019 (in Volume)
Table DC-TAB CAGR by Revenue and Volume, 2015-2019
4.1.4 Etomoxir Market, 2013-2018
Figure Etomoxir Market Size and Growth, 2015-2019 (USD Million)
Figure Etomoxir Market Size and Growth, 2015-2019 (in Volume)
Table Etomoxir CAGR by Revenue and Volume, 2015-2019
4.1.5 IB-MS Market, 2013-2018
Figure IB-MS Market Size and Growth, 2015-2019 (USD Million)
Figure IB-MS Market Size and Growth, 2015-2019 (in Volume)
Table IB-MS CAGR by Revenue and Volume, 2015-2019
4.1.6 Others Market, 2013-2018
Figure Others Market Size and Growth, 2015-2019 (USD Million)
Figure Others Market Size and Growth, 2015-2019 (in Volume)
Table Others CAGR by Revenue and Volume, 2015-2019
4.2 Market Forecast
4.2.1 Inebilizumab Market Forecast, 2020-2025
Figure Inebilizumab Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Inebilizumab Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Inebilizumab CAGR by Revenue and Volume, 2012-2024
4.2.2 GLX-1112 Market Forecast, 2020-2025
Figure GLX-1112 Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure GLX-1112 Market Estimates and Forecasts, 2020-2025 (in Volume)
Table GLX-1112 CAGR by Revenue and Volume, 2012-2024
4.2.3 DC-TAB Market Forecast, 2020-2025
Figure DC-TAB Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure DC-TAB Market Estimates and Forecasts, 2020-2025 (in Volume)
Table DC-TAB CAGR by Revenue and Volume, 2012-2024
4.2.4 Etomoxir Market Forecast, 2020-2025
Figure Etomoxir Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Etomoxir Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Etomoxir CAGR by Revenue and Volume, 2012-2024
4.2.5 IB-MS Market Forecast, 2020-2025
Figure IB-MS Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure IB-MS Market Estimates and Forecasts, 2020-2025 (in Volume)
Table IB-MS CAGR by Revenue and Volume, 2012-2024
4.2.6 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2012-2024
5 Market Segmentation by Application
5.1 Market Size
5.1.1 Hospital Market, 2013-2018
Figure Hospital Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2015-2019
5.1.2 Clinic Market, 2013-2018
Figure Clinic Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Clinic CAGR by Revenue and Volume, 2015-2019
5.1.3 Others Market, 2013-2018
Figure Others Market Size and Growth, 2015-2019 (USD Million)
Figure Market Size and Growth, 2015-2019 (in Volume)
Table Others CAGR by Revenue and Volume, 2015-2019
5.2 Market Forecast
5.2.1 Hospital Market Forecast, 2020-2025
Figure Hospital Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Hospital Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Hospital CAGR by Revenue and Volume, 2020-2025
5.2.2 Clinic Market Forecast, 2020-2025
Figure Clinic Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Clinic Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Clinic CAGR by Revenue and Volume, 2020-2025
5.2.3 Others Market Forecast, 2020-2025
Figure Others Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Others Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Others CAGR by Revenue and Volume, 2020-2025
6 Market Segmentation by Region
6.1 Market Size
6.1.1 Asia-Pacific
6.1.1.1 Asia-Pacific Market, 2015-2019
Figure Asia-Pacific Market Size and Growth, 2015-2019 (USD Million)
Figure Asia-Pacific Market Size and Growth, 2015-2019 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
6.1.1.2 Asia-Pacific Market by Type
Figure Asia-Pacific Market Size by Type
Figure Asia-Pacific Market Share by Type
6.1.1.3 Asia-Pacific Market by Application
Figure Asia-Pacific Market Size by Application
Figure Asia-Pacific Market Share by Application
6.1.2 North America
6.1.2.1 North America Market, 2015-2019
Figure North America Market Size and Growth, 2015-2019 (USD Million)
Figure North America Market Size and Growth, 2015-2019 (in Volume)
Table North America CAGR by Revenue and Volume, 2015-2019
6.1.2.2 North America Market by Type
Figure North America Market Size by Type
Figure North America Market Share by Type
6.1.2.3 North America Market by Application
Figure North America Market Size by Application
Figure North America Market Share by Application
6.1.3 Europe
6.1.3.1 Europe Market, 2015-2019
Figure Europe Market Size and Growth, 2015-2019 (USD Million)
Figure Europe Market Size and Growth, 2015-2019 (in Volume)
Table Europe CAGR by Revenue and Volume, 2015-2019
6.1.3.2 Europe Market by Type
Figure Europe Market Size by Type
Figure Europe Market Share by Type
6.1.3.3 Europe Market by Application
Figure Europe Market Size by Application
Figure Europe Market Share by Application
6.1.4 South America
6.1.4.1 South America Market, 2015-2019
Figure South America Market Size and Growth, 2015-2019 (USD Million)
Figure South America Market Size and Growth, 2015-2019 (in Volume)
Table South America CAGR by Revenue and Volume, 2015-2019
6.1.4.2 South America Market by Type
Figure South America Market Size by Type
Figure South America Market Share by Type
6.1.4.3 South America Market by Application
Figure South America Market Size by Application
Figure South America Market Share by Application
6.1.5 Middle East & Africa
6.1.5.1 Middle East & Africa Market, 2015-2019
Figure Middle East & Africa Market Size and Growth, 2015-2019 (USD Million)
Figure Middle East & Africa Market Size and Growth, 2015-2019 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
6.1.5.2 Middle East & Africa Market by Type
Figure Middle East & Africa Market Size by Type
Figure Middle East & Africa Market Share by Type
6.1.5.3 Middle East & Africa Market by Application
Figure Middle East & Africa Market Size by Application
Figure Middle East & Africa Market Share by Application
6.2 Market Forecast
6.2.1 Asia-Pacific Market Forecast, 2020-2025
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Asia-Pacific Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
6.2.2 North America Market Forecast, 2020-2025
Figure North America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure North America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table North America CAGR by Revenue and Volume, 2020-2025
6.2.3 Europe Market Forecast, 2020-2025
Figure Europe Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Europe Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Europe CAGR by Revenue and Volume, 2020-2025
6.2.4 South America Market Forecast, 2020-2025
Figure South America Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure South America Market Estimates and Forecasts, 2020-2025 (in Volume)
Table South America CAGR by Revenue and Volume, 2020-2025
6.2.5 Middle East & Africa Market Forecast, 2020-2025
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (USD Million)
Figure Middle East & Africa Market Estimates and Forecasts, 2020-2025 (in Volume)
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
7 Market Competitive
7.1 Global Market by Vendors
Table Global Secondary Progressive Multiple Sclerosis Drug Market by Vendors, 2015-2019 (in Volume)
Table Global Secondary Progressive Multiple Sclerosis Drug Market Share by Vendors, 2015-2019 (USD Million)
Table Global Secondary Progressive Multiple Sclerosis Drug Market Share by Vendors, 2015-2019 (in Volume)
7.2 Market Concentration
Figure Secondary Progressive Multiple Sclerosis Drug Market Concentration by Region
7.3 Price & Factors
Table Price Factors List
7.4 Marketing Channel
Figure Marketing Channels Overview
8 Major Vendors
8.1 AB Science SA
Table AB Science SA Profile List
Table Microecological Modulator Operating Data of AB Science SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.2 Actelion Ltd
Table Actelion Ltd Profile List
Table Microecological Modulator Operating Data of Actelion Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.3 Biogen, Inc.
Table Biogen, Inc. Profile List
Table Microecological Modulator Operating Data of Biogen, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.4 F. Hoffmann-La Roche Ltd.
Table F. Hoffmann-La Roche Ltd. Profile List
Table Microecological Modulator Operating Data of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.5 Genzyme Corporation
Table Genzyme Corporation Profile List
Table Microecological Modulator Operating Data of Genzyme Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.6 Glialogix, Inc.
Table Glialogix, Inc. Profile List
Table Microecological Modulator Operating Data of Glialogix, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.7 Immune Response BioPharma, Inc.
Table Immune Response BioPharma, Inc. Profile List
Table Microecological Modulator Operating Data of Immune Response BioPharma, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.8 Innate Immunotherapeutics Ltd
Table Innate Immunotherapeutics Ltd Profile List
Table Microecological Modulator Operating Data of Innate Immunotherapeutics Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.9 Kyorin Pharmaceutical Co., Ltd.
Table Kyorin Pharmaceutical Co., Ltd. Profile List
Table Microecological Modulator Operating Data of Kyorin Pharmaceutical Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.10 Mallinckrodt Plc
Table Mallinckrodt Plc Profile List
Table Microecological Modulator Operating Data of Mallinckrodt Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.11 MedDay SA
Table MedDay SA Profile List
Table Microecological Modulator Operating Data of MedDay SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.12 MedImmune, LLC
Table MedImmune, LLC Profile List
Table Microecological Modulator Operating Data of MedImmune, LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.13 Merck KGaA
Table Merck KGaA Profile List
Table Microecological Modulator Operating Data of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.14 Meta-IQ ApS
Table Meta-IQ ApS Profile List
Table Microecological Modulator Operating Data of Meta-IQ ApS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.15 Novartis AG
Table Novartis AG Profile List
Table Microecological Modulator Operating Data of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.16 Opexa Therapeutics, Inc.
Table Opexa Therapeutics, Inc. Profile List
Table Microecological Modulator Operating Data of Opexa Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
8.17 Xenetic Biosciences (UK) Limited
Table Xenetic Biosciences (UK) Limited Profile List
Table Microecological Modulator Operating Data of Xenetic Biosciences (UK) Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
9 Conclusion
Table Product Specifications of Secondary Progressive Multiple Sclerosis Drug
Table Products Segment of Secondary Progressive Multiple Sclerosis Drug
Table Global Secondary Progressive Multiple Sclerosis Drug Market by Type, 2011-2022 (USD Million)
Table Inebilizumab Overview
Table GLX-1112 Overview
Table DC-TAB Overview
Table Etomoxir Overview
Table IB-MS Overview
Table Others Overview
Table Application Segment of Secondary Progressive Multiple Sclerosis Drug
Table Global Secondary Progressive Multiple Sclerosis Drug Market by Application, 2011-2022 (USD Million)
Table Hospital Overview
Table Clinic Overview
Table Others Overview
Table Global Secondary Progressive Multiple Sclerosis Drug Market by Region, 2011-2022 (USD Million)
Table Cost of Secondary Progressive Multiple Sclerosis Drug
Table Market Dynamics
Table Policy of Secondary Progressive Multiple Sclerosis Drug
Table GDP of Major Countries
Table Technology of Secondary Progressive Multiple Sclerosis Drug
Table Market Entry of Secondary Progressive Multiple Sclerosis Drug
Table Inebilizumab CAGR by Revenue and Volume, 2015-2019
Table GLX-1112 CAGR by Revenue and Volume, 2015-2019
Table DC-TAB CAGR by Revenue and Volume, 2015-2019
Table Etomoxir CAGR by Revenue and Volume, 2015-2019
Table IB-MS CAGR by Revenue and Volume, 2015-2019
Table Others CAGR by Revenue and Volume, 2015-2019
Table Inebilizumab CAGR by Revenue and Volume, 2012-2024
Table GLX-1112 CAGR by Revenue and Volume, 2012-2024
Table DC-TAB CAGR by Revenue and Volume, 2012-2024
Table Etomoxir CAGR by Revenue and Volume, 2012-2024
Table IB-MS CAGR by Revenue and Volume, 2012-2024
Table Others CAGR by Revenue and Volume, 2012-2024
Table Hospital CAGR by Revenue and Volume, 2015-2019
Table Clinic CAGR by Revenue and Volume, 2015-2019
Table Others CAGR by Revenue and Volume, 2015-2019
Table Hospital CAGR by Revenue and Volume, 2020-2025
Table Clinic CAGR by Revenue and Volume, 2020-2025
Table Others CAGR by Revenue and Volume, 2020-2025
Table Asia-Pacific CAGR by Revenue and Volume, 2015-2019
Table North America CAGR by Revenue and Volume, 2015-2019
Table Europe CAGR by Revenue and Volume, 2015-2019
Table South America CAGR by Revenue and Volume, 2015-2019
Table Middle East & Africa CAGR by Revenue and Volume, 2015-2019
Table Asia-Pacific CAGR by Revenue and Volume, 2020-2025
Table North America CAGR by Revenue and Volume, 2020-2025
Table Europe CAGR by Revenue and Volume, 2020-2025
Table South America CAGR by Revenue and Volume, 2020-2025
Table Middle East & Africa CAGR by Revenue and Volume, 2020-2025
Table Global Secondary Progressive Multiple Sclerosis Drug Market by Vendors, 2015-2019 (in Volume)
Table Global Secondary Progressive Multiple Sclerosis Drug Market Share by Vendors, 2015-2019 (USD Million)
Table Global Secondary Progressive Multiple Sclerosis Drug Market Share by Vendors, 2015-2019 (in Volume)
Table Price Factors List
Table AB Science SA Profile List
Table Microecological Modulator Operating Data of AB Science SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Actelion Ltd Profile List
Table Microecological Modulator Operating Data of Actelion Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Biogen, Inc. Profile List
Table Microecological Modulator Operating Data of Biogen, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table F. Hoffmann-La Roche Ltd. Profile List
Table Microecological Modulator Operating Data of F. Hoffmann-La Roche Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Genzyme Corporation Profile List
Table Microecological Modulator Operating Data of Genzyme Corporation (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Glialogix, Inc. Profile List
Table Microecological Modulator Operating Data of Glialogix, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Immune Response BioPharma, Inc. Profile List
Table Microecological Modulator Operating Data of Immune Response BioPharma, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Innate Immunotherapeutics Ltd Profile List
Table Microecological Modulator Operating Data of Innate Immunotherapeutics Ltd (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Kyorin Pharmaceutical Co., Ltd. Profile List
Table Microecological Modulator Operating Data of Kyorin Pharmaceutical Co., Ltd. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Mallinckrodt Plc Profile List
Table Microecological Modulator Operating Data of Mallinckrodt Plc (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MedDay SA Profile List
Table Microecological Modulator Operating Data of MedDay SA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table MedImmune, LLC Profile List
Table Microecological Modulator Operating Data of MedImmune, LLC (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Merck KGaA Profile List
Table Microecological Modulator Operating Data of Merck KGaA (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Meta-IQ ApS Profile List
Table Microecological Modulator Operating Data of Meta-IQ ApS (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Novartis AG Profile List
Table Microecological Modulator Operating Data of Novartis AG (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Opexa Therapeutics, Inc. Profile List
Table Microecological Modulator Operating Data of Opexa Therapeutics, Inc. (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Table Xenetic Biosciences (UK) Limited Profile List
Table Microecological Modulator Operating Data of Xenetic Biosciences (UK) Limited (Sales Revenue, Sales Volume, Price, Cost, Gross Margin)
Similar Reports
This new 68-country report from LeadingMarketResearch.com is available by region, country, market segment, section, or individual test.
The report is designed to help current suppliers and potential market entrants identify and evaluate emerging opportunities in the global blood banking market during the next five years, and assist industry executives in developing effective business, new ...
- Publish Date: March 2, 2020
- $0
Hearing aids in the form of analog units have been traditionally present and used in India. Digital hearing units are finding increased growth in acceptability owing to the changing perceptions and growing base of the target consumer group. The Indian market is largely dependent on imports from foreign countries; domestic players in the country are ramping up their manufacturing facilities. The gr...
- Publish Date: March 10, 2011
- $950
The Indian medical devices market is largely dependent on imports from foreign countries. Although domestic players in the country are ramping up their manufacturing facilities, the foreign companies continue to enjoy a superior market share on account of their brand recognition, reliability, and technological superiority. The growing target base of consumers will boost sales and the market is exp...
- Publish Date: July 18, 2011
- $950
